Literature DB >> 29278875

LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma.

Hai-Feng Zhang, Wei Li, Yi-Di Han.   

Abstract

BACKGROUND: Recent findings have identified thousands of long non-coding RNAs (lncRNAs) and reveal that lncRNAs play crucial roles in the regulation of tumor development and progression. However, the clinical significance and potentially functional value of LINC00261 in hepatocellular carcinoma (HCC) remain unknown.
METHODS: Expression of LINC00261 was detected by qRT-PCR in HCC tissues and adjacent normal tissues. Kaplan-Meier analysis was used to assess the relationship between LINC00261 expression and the overall survival (OS) time. Cell proliferation and invasion were evaluated using MTT assay, cell colony formation assay and transwell assay. The protein expression was determined by western blot analysis.
RESULTS: In present study, we confirmed that LINC00261 was frequently lower in HCC tissues compared to adjacent normal tissues. Decreased LINC00261 expression associated with lager tumor size, TNM stage (III-IV) and poor overall survival time of HCC patients. The functional assays demonstrated that overexpression of LINC00261 in HCC cells inhibited cell proliferation, cell colony formation, cell invasion and EMT process in vitro. Moreover, we also demonstrated that upregulation of LINC00261 significantly inhibited Notch signaling by downregulating Notch1 and Hes-1 expression in HCC cells.
CONCLUSION: These results indicated that LINC00261 may be a potential target of HCC treatment.

Entities:  

Keywords:  Hepatocellular carcinoma; Hes-1; LINC00261; Notch1; long non-coding RNA

Mesh:

Substances:

Year:  2018        PMID: 29278875     DOI: 10.3233/CBM-170471

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  25 in total

1.  Apatinib inhibits cell proliferation and migration of osteosarcoma via activating LINC00261/miR-620/PTEN axis.

Authors:  Gang Han; Quanyi Guo; Ning Ma; Wenzhi Bi; Meng Xu; Jinpeng Jia
Journal:  Cell Cycle       Date:  2021-08-23       Impact factor: 5.173

2.  LncRNA LINC00261 overexpression suppresses the growth and metastasis of lung cancer via regulating miR-1269a/FOXO1 axis.

Authors:  Caixia Guo; Hongmei Shi; Yuli Shang; Yafei Zhang; Jiajia Cui; Hongtao Yu
Journal:  Cancer Cell Int       Date:  2020-06-26       Impact factor: 5.722

3.  New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma.

Authors:  Adriana Camargo Ferrasi; Geysson Javier Fernandez; Rejane Maria Tommasini Grotto; Giovanni Faria Silva; Joao Goncalves; Marina C Costa; Francisco J Enguita; Maria Inês de Moura Campos Pardini
Journal:  Sci Rep       Date:  2020-06-18       Impact factor: 4.379

4.  Comprehensive analysis of lncRNA-associated competing endogenous RNA network in tongue squamous cell carcinoma.

Authors:  Shusen Zhang; Ruoyan Cao; Qiulan Li; Mianfeng Yao; Yu Chen; Hongbo Zhou
Journal:  PeerJ       Date:  2019-02-06       Impact factor: 2.984

5.  Construction and Investigation of a lncRNA-Associated ceRNA Regulatory Network in Cholangiocarcinoma.

Authors:  Junyu Long; Jianping Xiong; Yi Bai; Jinzhu Mao; Jianzhen Lin; Weiyu Xu; Hui Zhang; Shuguang Chen; Haitao Zhao
Journal:  Front Oncol       Date:  2019-08-09       Impact factor: 6.244

6.  Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma.

Authors:  Lorenzo Ferrando; Gabriella Cirmena; Anna Garuti; Stefano Scabini; Federica Grillo; Luca Mastracci; Edoardo Isnaldi; Ciro Marrone; Roberta Gonella; Roberto Murialdo; Roberto Fiocca; Emanuele Romairone; Alberto Ballestrero; Gabriele Zoppoli
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

7.  Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.

Authors:  Dong Ouyang; Ruyi Li; Yaxian Li; Xueqiong Zhu
Journal:  Med Sci Monit       Date:  2019-10-25

8.  Long Noncoding RNA LINC00261 Reduces Proliferation and Migration of Breast Cancer Cells via the NME1-EMT Pathway.

Authors:  Guangxiu Guo; Sujuan Dai; Qing Chen
Journal:  Cancer Manag Res       Date:  2020-05-04       Impact factor: 3.989

9.  DAPT suppresses proliferation and migration of hepatocellular carcinoma by regulating the extracellular matrix and inhibiting the Hes1/PTEN/AKT/mTOR signaling pathway.

Authors:  Kaijie Qiu; Chenyang Ma; Lingchao Lu; Jie Wang; Baiwen Chen; Haixiang Mao; Yanmin Wang; Haibiao Wang
Journal:  J Gastrointest Oncol       Date:  2021-06

10.  LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity.

Authors:  Agnes Dorn; Markus Glaß; Carolin T Neu; Beate Heydel; Stefan Hüttelmaier; Tony Gutschner; Monika Haemmerle
Journal:  Cancers (Basel)       Date:  2020-05-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.